Safety, tolerability, and immunogenicity of an adult pneumococcal conjugate vaccine, V116 (STRIDE-3): a randomised, double-blind, active comparator controlled, international phase 3 trialHeather Platt, Christopher Galloway, Erik Buntinx et al.|The Lancet Infectious Diseases|2024Cited by 59